Amalgamated Bank Sells 1,470 Shares of HCA Healthcare, Inc. $HCA

Amalgamated Bank lessened its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.0% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 35,224 shares of the company’s stock after selling 1,470 shares during the period. Amalgamated Bank’s holdings in HCA Healthcare were worth $13,494,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Chung Wu Investment Group LLC bought a new stake in shares of HCA Healthcare in the second quarter valued at about $27,000. Ameriflex Group Inc. bought a new stake in shares of HCA Healthcare in the second quarter valued at about $27,000. Cheviot Value Management LLC bought a new stake in shares of HCA Healthcare in the first quarter valued at about $26,000. Saudi Central Bank bought a new stake in HCA Healthcare during the first quarter worth about $26,000. Finally, WPG Advisers LLC bought a new stake in HCA Healthcare during the first quarter worth about $27,000. Institutional investors own 62.73% of the company’s stock.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.30% of the stock is owned by company insiders.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $466.44 on Friday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $478.19. The firm has a 50 day moving average price of $420.00 and a two-hundred day moving average price of $385.66. The firm has a market cap of $109.14 billion, a price-to-earnings ratio of 18.03, a PEG ratio of 1.38 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same quarter last year, the business earned $4.90 EPS. The company’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. TD Cowen boosted their price objective on shares of HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a research report on Monday. Cowen reissued a “buy” rating on shares of HCA Healthcare in a report on Monday. The Goldman Sachs Group increased their target price on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a report on Monday. Finally, Wells Fargo & Company increased their target price on shares of HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 7th. Fourteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $473.53.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.